WHO ICTRP trial
Phase II exploratory, randomized, open-label, multicenter clinical study of…
ChiCTR2100051163 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100051163 |
|---|---|
| Public title | Phase II exploratory, randomized, open-label, multicenter clinical study of probiotics combined with or without loperamide in the prevention of pyrotinib-induced diarrhea |
| Scientific title | Phase II exploratory, randomized, open-label, multicenter clinical study of probiotics combined with or without loperamide in the prevention of pyrotinib-induced diarrhea |
| Primary sponsor | Sun Yat-Sen University Cancer Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | breast cancer |
| Interventions | Group 1:Loperamide monotherapy;Group 2:Probiotics;Group 3:Probiotics combined with loperamide |
| Registration date | Sep 15, 2021 |
| Target size | Group 1:30;Group 2:30;Group 3:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: